Bret D. Perry

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 667 citations · Full text

Immunology, Cell Death, Immunotherapy +21

Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection

Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 331 citations · Full text

Immunology, Janus Tyrosine Kinases, Immunotherapy +19

The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models

Elizabeth M. Kudlacz, Bret D. Perry, Perry S. Sawyer et al. · American Journal of Transplantation · 2003 · 154 citations

Signal Transduction, Medicine, Immunosuppressive Therapy +11

CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE−/− mice

Robert J. Aiello, Bret D. Perry, Patricia-Ann K. Bourassa et al. · Atherosclerosis · 2009 · 44 citations

Inflammation, Atherosclerotic Lesions, Vascular Disease +12

ANTAGONIZING LEUKOTRIENE B4 RECEPTORS DELAYS CARDIAC ALLOGRAFT REJECTION IN MICE

Elora J. Weringer, Bret D. Perry, Perry S. Sawyer et al. · Transplantation · 1999 · 29 citations